Venous Thromboembolism  >>  Evorel (estradiol transdermal)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Evorel (estradiol transdermal) / J&J
OPTIMISE, NCT02264743 / 2013-002094-22: Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy

Unknown status
4
60
Europe
Femoston Conti, Femoston Conti 0.5mg/2.5mg film-coated tablets versus, EVOREL® CONTI, Evorel Conti transdermal patch 25 mcg transdermal dose
Royal Brompton & Harefield NHS Foundation Trust, Chelsea and Westminster NHS Foundation Trust, Imperial College Healthcare NHS Trust
Venous Thrombosis, Insulin Resistance
11/14
11/15

Download Options